Cargando…
Immunological and metabolic characteristics of the Omicron variants infection
The Omicron variants of SARS-CoV-2, primarily authenticated in November 2021 in South Africa, has initiated the 5th wave of global pandemics. Here, we systemically examined immunological and metabolic characteristics of Omicron variants infection. We found Omicron resisted to neutralizing antibody t...
Autores principales: | Geng, Jiejie, Yang, Xu, Wang, Kun, Wang, Ke, Chen, Ruo, Chen, Zhi-Nan, Qin, Chuan, Wu, Guizhen, Wang, Youchun, Xu, Ke, Du, Peng, Liu, Jiangning, Chen, Shirui, Zhang, Tao, Sun, Xiuxuan, Guo, Ting, Shi, Ying, Zhang, Zheng, Wei, Ding, Lin, Peng, Wang, Qingyi, Yuan, Jing, Qu, Jiuxin, Zou, Jin, Liu, Yingxia, Lu, Hongzhou, Zhu, Ping, Bian, Huijie, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860238/ https://www.ncbi.nlm.nih.gov/pubmed/36681668 http://dx.doi.org/10.1038/s41392-022-01265-8 |
Ejemplares similares
-
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma
por: Geng, Jiejie, et al.
Publicado: (2021) -
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis
por: Wu, Jiao, et al.
Publicado: (2022) -
Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
por: Zhang, Peiyan, et al.
Publicado: (2022) -
Antiviral Efficacy and Safety of Molnupiravir Against Omicron Variant Infection: A Randomized Controlled Clinical Trial
por: Zou, Rongrong, et al.
Publicado: (2022) -
Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis
por: Chen, Shan, et al.
Publicado: (2023)